Quality of care indicators and their related outcomes: A population-based study in prostate cancer patients treated with radiotherapy

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 358-365

  Webber, Colleen ^a,b   Brundage, Michael D ^a,b   Siemens, David Robert ^b   Groome, Patti A ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

External beam radiotherapy; Prostatic neoplasms; Quality indicators, health care; Quality of health care

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER FILLING; CANCER CENTER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; HEALTH CARE QUALITY; HUMAN; IMMOBILIZATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME; URINE INCONTINENCE;

EXTERNAL BEAM RADIOTHERAPY; PROSTATIC NEOPLASMS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE;

ADULT; AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84881478265     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.04.017     Document Type: Article

References (42)

1. L. Cionini, G. Gardani, and P. Gabriele Quality indicators in radiotherapy Radiother Oncol 82 2007 191 200
2. B. Danielson, M. Brundage, and R. Pearcey Development of indicators of the quality of radiotherapy for localized prostate cancer Radiother Oncol 99 2011 29 36
3. A.R. Gagliardi, N. Fleshner, B. Langer, H. Stern, and A.D. Brown Development of prostate cancer quality indicators: a modified Delphi approach Can J Urol 12 2005 2808 2815
4. American Medical Association. Physician Consortium for performance improvement: prostate cancer 2013. Available at: http://www.ama-assn.org/ama1/ pub/upload/mm/pcpi/prostatecaws111907.pdf. Accessibility verified 3.6.2013.
5. M.S. Litwin, M. Steinberg, and J. Malin Prostate cancer patient outcomes and choice of providers: development of an infrastructure for quality assessment 2000 RAND Santa Monica (CA)
6. Quality research in radiation oncology. 2007 QRRO clinical performance measures (CPM): radiation oncology - prostate 2013. Available at: http://www.qrro.org/Prostate-CPM.pdf. Accessibility verified 3.6.2013.
7. E.G. Carmines, and R.A. Zeller Reliability and validity assessment 1979 Sage Publications Beverly Hills
8. A. Donabedian The quality of care: how can it be assessed? JAMA 260 1988 1743 1748
9. A. Donabedian Evaluating the quality of medical care Milbank Q 83 2005 691 729
10. M.S. Salzer, C.T. Nixon, L.J.A. Schut, M.S. Karver, and L. Bickman Validating quality indicators: quality as relationship between structure, process, and outcome Eval Rev 21 1997 292 309
11. J. Mant Process versus outcome indicators in the assessment of quality of health care Int J Qual Health Care 13 2001 475 480
12. M. Picchio, E. Giovannini, C. Crivellaro, L. Gianolli, N. di Muzio, and C. Messa Clinical evidence on PET/CT for radiation therapy planning in prostate cancer Radiother Oncol 96 2010 347 350
13. H.D. Thames, D. Kuban, and L.B. Levy The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995 Radiother Oncol 96 2010 6 12
14. G. Fellin, C. Fiorino, and T. Rancati Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study Radiother Oncol 93 2009 197 202
15. M. Pinkawa, B. Asadpour, and J. Siluschek Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder Radiother Oncol 83 2007 163 167
16. S. Malone, J. Szanto, and G. Perry A prospective comparison of three systems of patient immobilization for prostate radiotherapy Int J Radiat Oncol Biol Phys 48 2000 657 665
17. G.C. Bentel, L.B. Marks, G.W. Sherouse, D.P. Spencer, and M.S. Anscher The effectiveness of immobilization during prostate irradiation Int J Radiat Oncol Biol Phys 31 1995 143 148
18. W. Mackillop, J. Zhang-Salomons, P.A. Groome, and E. Holowaty Socioeconomic status and cancer survival in Ontario J Clin Oncol 15 1997 1680 1689
19. W.J. Mackillop, H. Fu, C.F. Quirt, P.F. Dixon, M.D. Brundage, and Y. Zhou Waiting for radiotherapy in Ontario Int J Radiat Oncol Biol Phys 30 1994 221 228
20. D.L. Boulos The contribution of comorbidity to survival outcomes in prostate cancer patients treated with curative intent 2002 Queen's University
21. K. Kwiatkowska Cancer in Ontario 1993-1994 1995 Ontario Cancer Treatment and Research Foundation Toronto
22. P.A. Groome, S.L. Rohland, D.R. Siemens, M. Brundage, J.P.W. Heaton, and W.J. Mackillop Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates Cancer 117 7 2011 3943 3952
23. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer J Clin Oncol 17 1999 168 172
24. A.B. Jani, C.M. Hand, and A.E. Lujan Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans Med Dosim 29 2004 42 48
25. A.Y. Ho, R.J. Burri, J.A. Cesaretti, N.N. Stone, and R.G. Stock Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy Int J Radiat Oncol Biol Phys 75 2009 16 22
26. B. Lau, S.R. Cole, and S.J. Gange Competing risk regression models for epidemiologic data Am J Epidemiol 170 2009 244 256
27. SAS Institute. SAS (Statistical Analysis Software) 2010;9.2.
28. H. Gronberg Prostate cancer epidemiology Lancet 361 2003 859 864
29. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
30. I. Thompson, J.B. Thrasher, and G. Aus Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106 2131
31. B. Moran, P. DeRose, and I. Hsu ACR appropriateness criteria: defining external beam irradiation in stage T1 and T2 prostate cancer Am Journal Clin Oncol 34 2011 636 647
32. U.M. O'Doherty, H.A. McNair, and A.R. Norman Variability of bladder filling in patients receiving radical radiotherapy to the prostate Radiother Oncol 79 2006 335 340
33. D.C. Miller, and C.S. Saigal Quality of care indicators for prostate cancer: progress toward consensus Urol Oncol 27 2009 427 434
34. S. Yao, and G.L. Lu-Yao Population-based study of relationships between hospital volume of prostatectomies, patient outcomes and length of hospital stay J Natl Cancer Inst 91 1999 1950 1956
35. D.A. Barocas, R. Mitchell, S.S. Chang, and M.S. Cookson Impact of surgeon and hospital volume on outcomes of radical prostatectomy Urol Oncol 28 2010 243 250
36. L.M. Ellison, B.J. Trock, N.R. Poe, and A.W. Partin The effect of hospital volume on cancer control after radical prostatectomy J Urol 173 2010 2094 2098
37. B.E. Hillner, T.J. Smith, and C.E. Desch Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care J Clin Oncol 18 2000 2327 2340
38. S.D. Walter, S.E. Birnie, and L.D. Marrett The geographic variation of cancer incidence in Ontario Am J Public Health 84 1994 367 376
39. Canadian Institute for Health Information Data quality documentation: discharge abstract database 2001-2002 2003 Canadian Institute for Health Information Ottawa
40. D.L. Boulos, P.A. Groome, and M.D. Brundage Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent Cancer 106 2006 1804 1814
41. G.J. van der Wielen, J.P. Mulhall, and L. Incrocci Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review Radiother Oncol 84 2007 107 113
42. J. Mainz Defining and classifying clinical indicators for quality improvement Int J Qual Health Care 15 2003 523 530